Next Article in Journal
Leukocyte Telomere Length as a Marker of Chronic Complications in Type 2 Diabetes Patients: A Risk Assessment Study
Previous Article in Journal
Genome-Wide Analysis of the Hsf Gene Family in Rosa chinensis and RcHsf17 Function in Thermotolerance
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cyclic Imines and Their Salts as Universal Precursors in the Synthesis of Nitrogen-Containing Alkaloids

by
Andrey Smolobochkin
1,*,
Almir Gazizov
1,
Nikita Sidlyaruk
1,
Nurgali Akylbekov
2,*,
Rakhmetulla Zhapparbergenov
2 and
Alexander Burilov
1
1
Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Arbuzov Str., 8, Kazan 420088, Russia
2
Laboratory of Engineering Profile, Department of Engineering Technology, Korkyt Ata Kyzylorda University, Aiteke bi Str., 29A, Kyzylorda 120014, Kazakhstan
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(1), 288; https://doi.org/10.3390/ijms26010288
Submission received: 12 December 2024 / Revised: 28 December 2024 / Accepted: 30 December 2024 / Published: 31 December 2024
(This article belongs to the Section Biochemistry)

Abstract

:
Alkaloids are predominantly nitrogen-containing heterocyclic compounds that are usually isolated from plants, and sometimes from insects or animals. Alkaloids are one of the most important types of natural products due to their diverse biological activities and potential applications in modern medicine. Cyclic imines were chosen as starting compounds for the synthesis of alkaloids due to their high synthetic potential. Thus, this review summarizes the achievements in the synthesis of various alkaloids from cyclic imines, paying special attention to stereoselective methods used for their preparation. Information on the biological activity of some alkaloids, their application and occurrence in natural objects is presented. Synthesis methods are classified based on the type of alkaloid obtained.

1. Introduction

Alkaloids have long been known for their biological activity [1,2,3,4,5]. The alkaloid content in plants is low as a rule, so it is often difficult to isolate this valuable product in sufficient quantities. In this case, the isolated alkaloid may contain various undesirable impurities [6]. In addition, the process of alkaloid isolation causes irreparable damage to the environment, since large numbers of plants and trees are destroyed. In some cases, such plants are on the verge of complete extinction [7]. In such instances, synthetic organic chemistry comes in useful. Currently, synthetic organic chemistry is being replenished with modern synthesis methods, which make it possible to obtain very complex target compounds.
This review article is devoted to methods used for the synthesis of various alkaloids based on cyclic imines. Cyclic imines are an important class of nitrogen-containing heterocyclic compounds that can act as precursors for the synthesis of alkaloids [8,9,10]. This is due to the fact that cyclic imines contain several reaction centers: a nucleophilic nitrogen atom and an imine bond with an electrophilic carbon atom. They are easy to synthesize [11,12,13].
The imine moiety can be reduced or oxidized and functionalized, which makes it a very valuable building block for alkaloid synthesis. Examples of valuable alkaloids synthesized from imines are shown in Figure 1. This figure shows the diversity of the structures of the resulting alkaloids based on cyclic imines. They include pyrrolizidine and indolizidine alkaloids with simple structures, as well as complex polycyclic alkaloids belonging to the classes Aspidosperma, Stephacidin, etc.
Currently, there are many publications in the literature devoted to the use of cyclic imines in the synthesis of alkaloids. This review is the first to summarize the scattered information on the synthesis of various classes of alkaloids. For convenience, we have grouped the material into sections according to the class of alkaloid.

2. Synthesis of Indolizidine Alkaloids

Indolizidine alkaloids are a broad class of natural compounds based on the indolizidine heterocycle [14,15] that have diverse biological activities. Swainsonine is a representative of indolizidine alkaloids, and was first isolated from the plant of Swainsona canescens species [16].
There are quite a lot of review articles related to the synthesis of Swainsonine [17,18,19,20], which indicates great interest in this alkaloid. Thus, it exhibits antitumor properties [21] and is an inhibitor of glycoprotein processing [22]. There is much evidence of Swainsonine poisoning in domestic animals that eat plants containing this alkaloid, which causes significant damage to livestock [23].
One of the methods used for the synthesis of Swainsonine (4) is the cyclization of imine 1 in boiling toluene, followed by treatment with tert-butylamine, potassium bis(trimethylsilyl)amide and borane–tetrahydrofuran, which leads to heterocycle 3 at 67% yield (Scheme 1). At the last stage, heterocycle 3 is treated with pyridinium p-toluenesulfonate (PPTS), which makes it possible to enantioselectively obtain (-)-Swainsonine (4) (>95% ee) [24].
In 2018, P. Unsworth and colleagues [25] reported efficient Ag(I)-catalyzed cyclization of ketamine 7 derived from 2-methyl-1-pyrroline 5. It should be noted that the authors who created this method isolated the desired bicyclic product 8 in quantitative yield with further hydrogenation with hydrogen using platinum (IV) oxide as a catalyst. During the final stage, Barton–McCombie deoxygenation was carried out with the formation of (±)-Indolizidine 209D (10) (Scheme 2). Unfortunately, the absence of enantioselectivity renders this method less applicable to the synthesis of biologically relevant compounds. This alkaloid was first isolated from the skin of tropical frogs of the genus Dendrobates [26]. It has a number of pharmacological properties, including blocking the neuromuscular transmission [27].
Serratezomine A (14) was isolated from the club moss Lycopodium serratum relatively recently, in 2000 [28]. The use of an imine 11 as a starting compound made it possible to synthesize Serratezomine A quite efficiently (Scheme 3). Thus, cyclization of the imine 11 to mesylate 12 and subsequent reduction with sodium cyanoborohydride led to heterocycle 13. Subsequent saponification and intramolecular cyclization resulted in Serratezomine A in a 33% yield [29].
Several review articles have been devoted to the synthesis of Crispine A (17) and Harmicine (20) [30,31]. This interest is due to the biological activity of these alkaloids [32,33]. It is very interesting that these alkaloids were synthesized before they were discovered in living objects. For example, Crispine A was isolated in 2002 from extracts of Carduus crispus [31]. It is quite simple to synthesize these alkaloids in almost quantitative yield by cyclization of amides 15 and 18 by an excess of phosphoryl chloride to heterocycles 16 and 19, which could be easily reduced to products 17 and 20 with sodium borohydride in methanol [34] (Scheme 4). The above reactions can be carried out at gram scale; however, only racemic compounds were obtained.
In a series of works [35,36], a method for synthesizing (R)-(+)-Crispine A, (R)-(+)-Harmicine and (R)-(+)-Desbromarborescidine is described, based on stereoselective hydrogenation of iminium salts 16, 19, 21 in the presence of ruthenium catalyst (Scheme 5).
The alkaloid (±)-Δ7-Mesembrenone (25) could be isolated in one stage [37] from iminium salt 24 by demethylation and hydrogenation by Krapcho with a yield of 79%; this alkaloid exhibits various biological activities [38] (Scheme 6). The drawback of this method is the lack of enatioselectivity. Mesembrenone was found to be dominant alkaloid in the leaves of sprouting bulbs and in the flowers Narcissus cv. Hawera [39] and Sceletium tortuosum [40]. Mesembrine significantly contributes to the anxiolytic effect of Zembrin [41].
The authors of [42] described a short process for synthesizing (±)-Jamtine (29). The key step was the condensation of 6,7-dimethoxy-3,4-dihydroisoquinoline 26 and tetrahydrophthalic anhydride 27 by microwave activation, which occurred in good yield and high diastereomeric selectivity. Reducing the amide function resulted in (±)-Jamtine (Scheme 7). The alkaloid Jamtinine was isolated from whole plants of Cocculus hirsutus [43], which are renowned for their therapeutic properties [44,45,46].
(-)-Isoschizogamine (34) was first isolated in 1963 from the plant Schizozygia caffaeoides [47]. It exhibited antimicrobial and antifungal activity in micromolar concentrations [48]. Reacting compounds 30 and 31 under microwave irradiation resulted in iminium salt 32, which was dissolved in 1,2-dichloroethane/1,2-dichlorobenzene and irradiated again (Scheme 8). Under these conditions, hexacyclic compound 33 was isolated in 45% yield as a mixture of two diastereomers (dr = 1:1). Oxidation of compound 33 to selenoxide followed by syn-elimination led to the production of (-)-Isoschizogamine [49].

3. Synthesis of Pyrrolizidine Alkaloids

Pyrrolizidine alkaloids are a group of compounds that predominantly originate from plants which contain a pyrrolizidine fragment in their structure. It should be noted that they provide a protective function for plants, making them poisonous [50]. However, these alkaloids can have useful medicinal properties, since they exhibit hepatotoxic, neurotoxic, genotoxic, and cytotoxic activities [51,52,53,54].
Pyrrolizidine alkaloids are predominantly synthesized from 3,4-dihydro-2H-pyrrole 1-oxide derivatives. Thus, in [55], a method for the synthesis of the alkaloid (+)-Hyacinthacine A2 (38) is described; it was isolated from the bulbs of Muscari armeniacum (Hyacinthaceae) and showed promising inhibitory activity against glycosidases [56,57]. Thus, nitrone 35 was treated with SmI2 and ethyl acrylate was added. Treatment of the reaction mixture with potassium carbonate in ethanol/water resulted in a lactam 36. Reducing the lactam 36 using lithium aluminum hydride made it possible to obtain pyrrolizidine 37. Then, the benzyl groups were removed, which made it possible to isolate (+)-Hyacinthacine A2 (Scheme 9).
A similar strategy was used by P. Gilles and S. Py [58] to synthesize (+)-Australine (42), which was first isolated from the seeds of Castanospmnum australe [59]. This alkaloid is interesting because it inhibits amyloglucosidase and the breakdown of glycoproteins [60]. A recent review article [61] was devoted to the synthesis of Australine and its derivatives, which is indicative of the growing interest in this alkaloid. This alkaloid is capable of inhibiting amyloglucosidase and glycoproteins breakdown [60]. A recent review article [61]. The interaction of nitrone 35 with acrylate led to lactam 39 with a yield of 49% in the form of a single diastereomer. Then, through a series of stages, the target product 42 was isolated, and the last stage proceeded with quantitative yield (Scheme 10). We note the good yield and high enantioselectivity of the proposed reaction sequence.
(+)-Heliotridine (48) is a 1,2-unsaturated pyrrolizidine alkaloid which presents in plants of the Heliotropium genus [62,63]. Total synthesis of (+)-Heliotridine (48) was achieved by F.M. Cordero and colleagues [64]; their method is based on a highly selective 1,3-dipolar cycloaddition of (S)-3-tert-butoxypyrroline N-oxide 43 with ethyl 4-bromocrotone. The total yield of the product 48 was 17% (Scheme 11).
The asymmetric total synthesis of (-)-Rosmarinecine (53), first isolated in 1940 from the South African plant Senecio retrorsus [65], was carried out in three stages [66]. The key step was the reaction of nitrone 49 with an ester catalyzed by Candida antarctica lipase B (CAL-B). This was followed by intramolecular [3+2] dipolar cycloaddition, which resulted in a heterocycle 51 with an enantiomeric excess of 92%. Hydrogenation of the N–O bond and subsequent reduction with Red-Al (Sodium bis(2-methoxyethoxy)aluminum hydride) led to (-)-Rosmarinecine (53) (Scheme 12). The high enantioselectivity of this approach should be emphasized.
Nitropolyzonamine is one of the few alkaloids of animal origin. This unusual alkaloid, produced by the centipede Polyzonium rosalbum [67,68], protects the organism from enemies. The authors of [69] describe a method used to synthesize (4S,5R,6S)-(+)-Nitropolyzonamine (57). The starting compound is an enantiomerically pure imine 56, which was obtained from heterocycle 54 by treatment with D-(-)-tartaric acid. Conversion of the salt to the free base allowed the enantiospecific isolation of S-(+)-Polyzonimine (56) with quantitative yield, which reacted with 3-iodo-1-nitropropane to form (4S,5R,6S)-(+)-Nitropolyzonamine (Scheme 13). The proposed approach benefits from its short synthetic scheme (3 stages), high enantioselectivity and use of readily available D-(-)-tartaric acid as both a reagent and a catalyst.

4. Synthesis Quinolizidine Alkaloids

There are more than 200 known quinolizidine alkaloids, which are united by the presence of a 1-azabicyclo[4.4.0]decane core [70,71]. Like most alkaloids, quinolizidine alkaloids protect plants from pests and diseases, i.e., they perform a protective function. Despite this, many representatives of this class of alkaloids are utilized by humans [72]. Reduction of (-)-Senepodine G (58) with sodium borohydride in methanol resulted in (-)-Cermizine C (59) [73] (Scheme 14). This alkaloid is found in plants of the genus Lycopodium [74].
The work [75] describes a method used for the synthesis of Evodiamine (62) from dihydrocarboline 60 and anthranilic acid 61 (Scheme 15). The great potential of evodiamine as a new drug is described in sufficient detail in review articles that summarize the biological activity of this alkaloid [76,77,78,79,80]. The same work [75] describes the method used to synthesize an equally important alkaloid, Cavidine (67). Thus, Cavidine exhibits various biological activities, such as antiulcer [81] and anti-inflammatory effects [82], and improves lung function [83]. In the first step, the reaction of imine 63 with an acid produced ester 65, which was hydrolyzed and decarboxylated using lithium hydroxide in aqueous THF, followed by reduction with lithium aluminum hydride, resulting in alcohol 66 as a single diastereoisomer. Mesylation followed by deoxygenation resulted in (±)-Cavidine.
In [84], acetal 69 and 2,3,4,5-tetrahydropyridine 69 were used as starting compounds for the preparation of alkaloids (±)-α,β-Myrifabral A (72) and B (73), the reaction of which resulted in lactam 70. Reducing lactam 70 with lithium aluminum hydride led to the formation of amino alcohol 71 in the form of a mixture of two diastereomers; however, via column chromatography, it was possible to isolate the main diastereomer with 81% yield. Treating alcohol 71 with hydrochloric acid promoted cyclization, leading to the formation of (±)-α,β-Myrifabral A (72) at 92% yield. It should be noted that synthesis is possible on a scale of several grams. Treating acetal 71 with hydrochloric acid and N,N-diethyl-O-methylhydroxylamine led to a mixture of (±)-α,β-Myrifabral A and B, which were successfully separated (Scheme 16). It should be noted that the Myrifabral alkaloids are a relatively new, small family of polycyclic alkaloids. These alkaloids were first isolated in 2002 from the plant of Myrioneuron nutans species [85,86], and are currently being actively studied.
The work [87] describes the enantioselective synthesis of the alkaloid (+)-Sparteine (77), based on the Beckmann photo-rearrangement (Scheme 17). Photolysis in benzene at 254 nm provided a smooth rearrangement of lactam 76 with a yield of 76%. Removal of the lactam carbonyl using lithium aluminum hydride led to (+)-Sparteine in a virtually quantitative yield. The key photochemical stage proceeds in mild conditions without any metal catalysts and provides entry to the rather complex scaffold. The operational simplicity and readily available reagents render photochemical transformations very promising for industrial applications. It should be noted that Sparteine is one of the few alkaloids that is currently used in medical practice as an antiarrhythmic agent and sodium channel blocker. In addition, Sparteine is widely used in asymmetric synthesis as a chiral ligand [88,89], which makes this alkaloid a very valuable product.

5. Synthesis of Aspidosperma Alkaloids

Aspidosperma alkaloids are a large family of naturally occurring and structurally related indole alkaloids with diverse biological activities [90,91]. Therefore, this important class of compounds has been the subject of review articles related to their synthesis [92,93,94]. Aspidospermidine is the simplest representative of this class of alkaloids, from which more complex structural alkaloids are synthesized. Notably, plants were the first source of bioactive compounds due to their abundance, diversity and availability. Thus, the semi-synthetic drugs often have better availability. There are a number of advantages associated with semi-synthetic alkaloid-based drugs, including a short synthesis scheme, a high yield of optically pure product, increased bioavailability, improved solubility, decreased toxicity, and increased selectivity [95,96]. Aspidospermidine (79) was synthesized quite easily from another alkaloid, Eburenine (78), by reduction with sodium borohydride or lithium aluminum hydride [97,98,99,100,101,102,103,104] (Scheme 18). The alkaloid Eburenine (78) is a major component of Rhazya stricta [105,106].
Treatment of imine 80 lithium aluminum hydride and acetic anhydride/pyridine led to the production of a mild form of (-)-Aspidospermine (81) [99,107] (Scheme 19). Aspidospermine was first isolated from a tree of the genus Aspidosperma. Aspidospermine was found to possess adrenergic blocking activities for a variety of urogenital tissues [108], antimalarial activity [109], etc. Dehydrodeacetylaspidospermine (80) is a component of plants of the genus Winchia [110].
The addition of trimethylsilyl cyanide to imine 78 in ethanol allowed the synthesis of (+)-Winchinine B (82), which was first isolated from the leaves of Winchia calophylla (Scheme 20) [111,112]. High enantioselectivity in the absence of any chiral catalysts is the salient feature of this reaction.
Addition of water to (-)-Kopsifoline D (83) yielded (-)-Kopsifoline D hydrate (84) (Scheme 21). It should be noted that a synthesis method consisting of simply stirring the imine 83 in a tetrahydrofuran–water mixture allowed the product to be isolated at 95% yield [113].
In a series of papers [98,114,115,116], enantioselective synthesis of the alkaloids (−)-Tabersonine (86), (−)-Vincadifformine (87), and (−)-Aspidospermidine (79) (Scheme 22) is described. Indolenine (85) serves as a key intermediate product in the synthesis of Aspidosperma alkaloids. Complete hydrogenation of Indolenine (85) in the presence of Adams catalyst in ethanol at room temperature led to (−)-Aspidospermidine with a yield of 75%. From indolenine, it is also possible to synthesize (−)-Tabersonine and (−)-Vincadifformine, with product yields exceeding 70%. Here, we would like to mention the alkaloid (−)-Tabersonine, since it has a variety of biological activities: it suppresses the formation of amyloid fibrils [117], attenuates kidney damage caused by obesity [118], and exhibits antitumor [119,120] and anti-inflammatory [121] activities.
An original enantioselective synthetic route has been proposed for the preparation of the alkaloids (+)-10-Oxocylindrocarpidine (91), (+)-Cylindrocarpidine (93), and (+)-Aspidospermine (81) [122]. The key steps of the approach are reduction to the free amine and its acylation to compound 88. For the synthesis of (+)-10-Oxocylindrocarpidine, the alkene was oxidized with potassium osmate to aldehyde 90 in 85% yield. Subsequent oxidation of the aldehyde group with I2 in the presence of potassium hydroxide produced the target molecule 91. Oxidation of compound 92 under the same conditions produced (+)-Cylindrocarpidine (93). Using a two-step transformation involving mercaptalization followed by hydrogenation with Raney nickel, (+)-Aspidospermine (81) was synthesized (Scheme 23).
The reduction of an imine to an amine is described; this amine, in turn, underwent an intramolecular Heck reaction to form (-)-Dehydrotubifolin (96). (-)-Tubifolin (97) was synthesized by selective hydrogenation of the double bond in (-)-Dehydrotubifolin (96), and subsequent reduction of the imine group led to the formation of (-)-Tubifolidin (98) (Scheme 24) [123,124].
Reduction of compound 99 with lithium aluminum hydride in tetrahydrofuran resulted in the formation of amine 100. Amine 100 was finally converted to Tubifolidin (98) in the presence of tris(triphenylphosphine) rhodium (I) chloride in benzene and 2-propanol at room temperature at 67% yield (Scheme 25) [125].
An asymmetric total synthesis of (+)-Vincadifformine (87) and (+)-Ervinceine (103) is described in [126,127]. Thus, indole 101 reacted with imine 102 in the presence of potassium iodide in DMF to form alkaloids (Scheme 26). Interestingly, the authors successfully isolated an enantiomerically pure compound without use of chiral catalysts. Moreover, the reaction was carried out at elevated temperature, which is not typical for asymmetric synthesis.
The stereoselective reduction of the imine 104 followed by methylation to yield polycycle 106 deserves special attention [128,129]. Saponification of the ester 105 and subsequent subjection of the resulting carboxylic acid to oxidative lactone formation conditions resulted in the formation of (-)-Aspidophytine (106) (Scheme 27). (-)-Aspidophytine (106) was first obtained from Haplophyton crooksii, or the common cockroach plant, which is native to North America [130]. Components of this plant have been used for thousands of years to control cockroaches. The mechanism of action is probably related to the inhibition of acetylcholinesterase [131].

6. Synthesis of Steroidal Alkaloids

Steroid alkaloids, as the name suggests, have a steroid skeleton with corresponding functional groups. Steroid alkaloids exhibit a wide range of biological activities, including chemotherapeutic [132,133,134], antiviral [135], and antimicrobial [136] activity, and can be used to treat osteoporosis [137].
For the synthesis of Solanidine (109), polycycle 107 was used as a starting compound, which was sequentially reduced with sodium borohydride and Red-Al [138] (Scheme 28). This alkaloid is interesting because it is a very important precursor for the synthesis of hormones and some pharmacologically active compounds, such as progesterone and cortisone [139]. Solanidine is a poisonous alkaloid that is found in fairly large quantities in plants of the Solanaceae family. This has made Solanidine a precursor for the further synthesis of useful compounds. Solanidine itself is a biomarker for various cytochrome CYP2D6 genes [140,141].
The synthesis of Demissidine (113) is described in [142]. Thus, steroid 110 reacted with mesyl chloride to form compound 111, which spontaneously cyclized to iminium salt 112 in the presence of triethylamine (Scheme 29); compound 112 easily transformed the target compound 113 in the presence of sodium borohydride.

7. Synthesis of Other Alkaloids

This section contains a description of the syntheses of alkaloids that were not included in the previous sections. (-)-Flueggine A (116) was isolated from the leaves of Flueggea virosa in 2011 [143]. The leaves of this plant are used in traditional Chinese medicine to treat skin diseases, and this alkaloid is likely responsible for the effectiveness of the treatment [144]. In [145,146] the synthesis of (-)-Norsecurinine (115) based on the 1,3-dipolar addition of compound 115 in boiling toluene for 12 hours is described (Scheme 30).
Calofilin A (119) was first isolated in 2012 from Winchia calophylla [147]. Since this nitrogen- and oxygen-containing alkaloid contains many different functional groups and several fused rings, complete synthesis was carried out for the first time in 2016 under the guidance of Professor Liansuo Zu [148]. Calofilin A (119) could be synthesized in two stages from imine (Scheme 31). Imine 117 reacted with formaldehyde in the presence of sodium hydride as a base and dimethylformamide as a solvent to form compound 118 in 34% yield. Finally, by N-methylation and saponification, it was possible to obtain the natural product Calofilin A (119) [149].
In 2010, Kam and co-workers isolated (-)-Leucoridins A (122) and C (123) from the bark of Leuconotis griffithii [150]. The authors of [151,152] proposed a fairly effective method for the synthesis of these complex alkaloids. In the first stage, alcohol 120 was dehydrated with trifluoroacetic acid, which led to the formation of (-)-Dihydrovalparicin (121). Replacing the solvent with toluene and boiling for 16 h led to the formation of (-)-Leucoridin A (122) at 40% yield. The addition of hydrochloric acid to (-)-Leucoridine A (122) resulted in the opening of the indolenine ring to form (-)-Leucoridine C (123) at 47% yield (Scheme 32).

8. Conclusions

In conclusion, we note that the development of new methods for the synthesis of alkaloids is of great practical importance in the search for new drugs of plant origin. Since the alkaloid content in plant materials can be extremely low, synthetic methods will make it possible to obtain these valuable products in sufficient quantities. The emergence of drug resistance is also important, so the development of effective synthesis methods is becoming increasingly important.
Analysis of data from the literature indicates that imines are successfully involved in the synthesis of not only relatively simple alkaloids of the pyrrolizidine and indolizidine series, but also of a large group of structurally complex Aspidosperma alkaloids. This is primarily due to the wide variety of types of reactions into which cyclic imines can participate. First of all, they may be reduced to amines under mild conditions, with almost quantitative yield of the product, which in turn participate in further reactions.
Reactions of imines with nucleophiles are caused by the carbon atom; they are very diverse and are widely used in the synthesis of alkaloids. This is a key step for the synthesis of alkaloids such as (+)-Winchinine B, (-)-Kopsifoline D hydrate. Alkylation of the nitrogen atom leads to iminium salts, which ultimately makes it possible to obtain (-)-Swainsonine, Serratezomine A, and (-)-Isoschizogamine. Imines undergo various cycloaddition reactions, which lead to the formation of (-)-Rosmarinecine, (±)-α,β-Myrifabral A, (-)-Norsecurinine, and (+)-Heliotridine. Imines undergo ring opening much less frequently, so this process makes it possible to synthesize the alkaloid (-)-Leucoridine C, which has a complex structure.
A feature of cyclic imines is their ability to react under mild conditions. These conditions play a key role in preventing racemization of the precursor, which is a very big problem in multi-step syntheses of optically pure compounds.
However, the inevitable drawback of the imine-based approaches is the hydrolytic instability of most of imines, which implies strictly anhydrous conditions, hindering their syntheses and increasing their costs.
Photochemical transformations are among the most promising “green chemistry” approaches for the synthesis of natural products starting from imines. Nonetheless, only the photochemical reaction of octahydro-2H-quinolizines is known so far, which has been applied to the synthesis of a sparteine. Thus, further studies in this field are of great interest.
The data presented in this review indicate that, every year, dozens of new alkaloids are isolated from plants, which are later synthesized by chemists in laboratory settings. Therefore, the chemistry of cyclic imines is currently actively developing and is a popular area of modern organic and medicinal chemistry.

Author Contributions

Conceptualization—A.S. and A.G.; writing—original draft preparation—A.S. and A.G.; software —N.S.; writing—review and editing—A.S., A.G., R.Z., N.A. and A.B.; project administration—A.B. All authors have read and agreed to the published version of the manuscript.

Funding

The literature survey, analysis of the collected data, and writing of Sections 2–4 have been funded by the Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan (Grant No. AP23487716). The literature survey, analysis of the collected data, and writing of Sections 5–7 have been funded by the government assignment of the FRC Kazan Scientific Center of RAS.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Wink, M. A Short History of Alkaloids. In Alkaloids; Springer: Boston, MA, USA, 1998; pp. 11–44. [Google Scholar]
  2. Ding, Y.-Y.; Zhou, H.; Deng, P.; Zhang, B.-Q.; Zhang, Z.-J.; Wang, G.-H.; Zhang, S.-Y.; Wu, Z.-R.; Wang, Y.-R.; Liu, Y.-Q. Antimicrobial Activity of Natural and Semi-Synthetic Carbazole Alkaloids. Eur. J. Med. Chem. 2023, 259, 115627. [Google Scholar] [CrossRef]
  3. Uzor, P.F. Alkaloids from Plants with Antimalarial Activity: A Review of Recent Studies. Evid.-Based Complement. Altern. Med. 2020, 2020, 8749083. [Google Scholar] [CrossRef] [PubMed]
  4. Lin, S.X.; Curtis, M.A.; Sperry, J. Pyridine Alkaloids with Activity in the Central Nervous System. Bioorganic Med. Chem. 2020, 28, 115820. [Google Scholar] [CrossRef]
  5. Rajput, A.; Sharma, R.; Bharti, R. Pharmacological Activities and Toxicities of Alkaloids on Human Health. Mater. Today Proc. 2022, 48, 1407–1415. [Google Scholar] [CrossRef]
  6. Silva, G.L.; Lee, I.-S.; Kinghorn, A.D. Special Problems with the Extraction of Plants. In Natural Products Isolation; Humana: Totowa, NJ, USA, 1998; pp. 343–363. [Google Scholar]
  7. Dash, A.K. The Dark Side of Paclitaxel. Oncol. Rev. 2010, 4, 71–72. [Google Scholar] [CrossRef]
  8. Varga, S.; Angyal, P.; Martin, G.; Egyed, O.; Holczbauer, T.; Soós, T. Total Syntheses of (−)-Minovincine and (−)-Aspidofractinine through a Sequence of Cascade Reactions. Angew. Chem. Int. Ed. 2020, 59, 13547–13551. [Google Scholar] [CrossRef]
  9. Kataja, A.O.; Masson, G. Imine and Iminium Precursors as Versatile Intermediates in Enantioselective Organocatalysis. Tetrahedron 2014, 70, 8783–8815. [Google Scholar] [CrossRef]
  10. Cheng, D.; Shao, Y. Organocatalytic Asymmetric Transformations Involving the Cyclic Imine Moiety in Indole and Isoindole Related Heterocycles. Adv. Synth. Catal. 2018, 360, 3614–3642. [Google Scholar] [CrossRef]
  11. Iwanejko, J.; Wojaczyńska, E. Cyclic Imines—Preparation and Application in Synthesis. Org. Biomol. Chem. 2018, 16, 7296–7314. [Google Scholar] [CrossRef]
  12. Kuang, Z.; Ding, X.-B.; Furkert, D.P.; Brimble, M.A. Synthesis and α-Functionalisation of Cyclic Imines. Synlett 2024, 35, 1813–1816. [Google Scholar] [CrossRef]
  13. Xu, Z.; Kovács, E. Beyond Traditional Synthesis: Electrochemical Approaches to Amine Oxidation for Nitriles and Imines. ACS Org. Inorg. Au 2024, 4, 471–484. [Google Scholar] [CrossRef]
  14. Zhang, J.; Morris-Natschke, S.L.; Ma, D.; Shang, X.; Yang, C.; Liu, Y.; Lee, K. Biologically Active Indolizidine Alkaloids. Med. Res. Rev. 2021, 41, 928–960. [Google Scholar] [CrossRef]
  15. Chakraborty, I.; Jana, S. Synthetic Developments on the Indolizidine Alkaloid, Harmicine. Synthesis 2013, 45, 3325–3331. [Google Scholar] [CrossRef]
  16. Dorling, P.R.; Huxtable, C.R.; Colegate, S.M. Inhibition of Lysosomal α-Mannosidase by Swainsonine, an Indolizidine Alkaloid Isolated from Swainsona Canescens. Biochem. J. 1980, 191, 649–651. [Google Scholar] [CrossRef] [PubMed]
  17. El Nemr, A. Synthetic Methods for the Stereoisomers of Swainsonine and Its Analogues. Tetrahedron 2000, 56, 8579–8629. [Google Scholar] [CrossRef]
  18. Tan, X.; Chen, A.J.; Wu, B.; Zhang, G.-S.; Ding, G. Advance of Swainsonine Biosynthesis. Chin. Chem. Lett. 2018, 29, 417–422. [Google Scholar] [CrossRef]
  19. Pyne, S. Recent Developments on the Synthesis of (-)-Swainsonine and Analogues. Curr. Org. Synth. 2005, 2, 39–57. [Google Scholar] [CrossRef]
  20. Drogalin, A. Advances in the Chemistry of (−)-D-Swainsonine. Chem. Sel. 2022, 7, e202201905. [Google Scholar] [CrossRef]
  21. Olden, K.; Breton, P.; Grzegorzewski, K.; Yasuda, Y.; Gause, B.L.; Oredipe, O.A.; Newton, S.A.; White, S.L. The Potential Importance of Swainsonine in Therapy for Cancers and Immunology. Pharmacol. Ther. 1991, 50, 285–290. [Google Scholar] [CrossRef]
  22. Elbein, A.D.; Solf, R.; Dorling, P.R.; Vosbeck, K. Swainsonine: An Inhibitor of Glycoprotein Processing. Proc. Natl. Acad. Sci. USA 1981, 78, 7393–7397. [Google Scholar] [CrossRef]
  23. Li, B.; Zhang, C.; Zhu, Y.; Sun, P.; Fan, S.; Wang, W.; Tian, Y.; Lu, H. Development of Novel Formulation for Sustained Release of Drug to Prevent Swainsonine-Containing Plants Poisoning in Livestock. Animals 2023, 13, 2646. [Google Scholar] [CrossRef]
  24. Punniyamurthy, T.; Irie, R.; Katsuki, T. Short Step Enantioselective Synthesis of (-)-Swainsonine. Chirality 2000, 12, 464–468. [Google Scholar] [CrossRef]
  25. Ho, H.E.; James, M.J.; O’Brien, P.; Taylor, R.J.K.; Unsworth, W.P. Ag(I)-Catalyzed Synthesis of Azabicyclic Alkaloid Frameworks from Ketimine-Tethered Ynones: Total Synthesis of Indolizidine 209D. Org. Lett. 2018, 20, 1439–1443. [Google Scholar] [CrossRef]
  26. Daly, J.W.; Myers, C.W.; Whittaker, N. Further Classification of Skin Alkaloids from Neotropical Poison Frogs (Dendrobatidae), with a General Survey of Toxic/Noxious Substances in the Amphibia. Toxicon 1987, 25, 1023–1095. [Google Scholar] [CrossRef]
  27. Takahata, H.; Kubota, M.; Ihara, K.; Okamoto, N.; Momose, T.; Azer, N.; Eldefrawi, A.T.; Eldefrawi, M.E. New Synthesis of All the Four Stereoisomers of Indolizidine 209D and Their Affinity for Nicotinic Acetylcholine Receptor. Tetrahedron Asymmetry 1998, 9, 3289–3301. [Google Scholar] [CrossRef]
  28. Morita, H.; Arisaka, M.; Yoshida, N.; Kobayashi, J. Serratezomines A−C, New Alkaloids from Lycopodium s Erratum Var. s Erratum. J. Org. Chem. 2000, 65, 6241–6245. [Google Scholar] [CrossRef]
  29. Chandra, A.; Pigza, J.A.; Han, J.-S.; Mutnick, D.; Johnston, J.N. Total Synthesis of the Lycopodium Alkaloid (+)-Serratezomine A. J. Am. Chem. Soc. 2009, 131, 3470–3471. [Google Scholar] [CrossRef]
  30. Mohan, C.; Krishna, R.B.; Sivanandan, S.T.; Ibnusaud, I. Synthesis of Pyrrolo[2,1-a]Isoquinoline Class of Natural Product Crispine A. Eur. J. Org. Chem. 2021, 2021, 4911–4926. [Google Scholar] [CrossRef]
  31. Pässler, U.; Knölker, H.-J. The Pyrrolo[2,1-a]Isoquinoline Alkaloids. In The Alkaloids: Chemistry and Biology; Academic Press: Cambridge, MA, USA, 2011; pp. 79–151. [Google Scholar]
  32. Zhang, L.; Li, D.; Yu, S. Pharmacological Effects of Harmine and Its Derivatives: A Review. Arch. Pharmacal Res. 2020, 43, 1259–1275. [Google Scholar] [CrossRef]
  33. Spindola, H.M.; Vendramini-Costa, D.B.; Rodrigues, M.T.; Foglio, M.A.; Pilli, R.A.; Carvalho, J.E. The Antinociceptive Activity of Harmicine on Chemical-Induced Neurogenic and Inflammatory Pain Models in Mice. Pharmacol. Biochem. Behav. 2012, 102, 133–138. [Google Scholar] [CrossRef]
  34. Saha, S.; Venkata Ramana Reddy, C.; Patro, B. Facile Two-Step Synthesis of Crispine A and Harmicine by Cyclopropylimine Rearrangement. Tetrahedron Lett. 2011, 52, 4014–4016. [Google Scholar] [CrossRef]
  35. Szawkało, J.; Czarnocki, S.J.; Zawadzka, A.; Wojtasiewicz, K.; Leniewski, A.; Maurin, J.K.; Czarnocki, Z.; Drabowicz, J. Enantioselective Synthesis of Some Tetrahydroisoquinoline and Tetrahydro-β-Carboline Alkaloids. Tetrahedron Asymmetry 2007, 18, 406–413. [Google Scholar] [CrossRef]
  36. Szawkało, J.; Zawadzka, A.; Wojtasiewicz, K.; Leniewski, A.; Drabowicz, J.; Czarnocki, Z. First Enantioselective Synthesis of the Antitumour Alkaloid (+)-Crispine A and Determination of Its Enantiomeric Purity by 1H NMR. Tetrahedron Asymmetry 2005, 16, 3619–3621. [Google Scholar] [CrossRef]
  37. Gallagher-Duval, S.; Lapointe, V.; Bélanger, G. Functionalized Polyhydroquinolines from Amino Acids Using a Key One-Pot Cyclization Cascade and Application to the Synthesis of (±)-Δ 7-Mesembrenone. Org. Lett. 2021, 23, 8606–8611. [Google Scholar] [CrossRef]
  38. Krstenansky, J.L. Mesembrine Alkaloids: Review of Their Occurrence, Chemistry, and Pharmacology. J. Ethnopharmacol. 2017, 195, 10–19. [Google Scholar] [CrossRef]
  39. Sidjimova, B.; Denev, R.; Nikolova, M.; Bastida, J.; Berkov, S. Dynamics of Alkaloid Accumulation in Narcissus Cv. Hawera: A Source of Sceletium-Type Alkaloids. Z. Für Naturforschung C 2024, 79, 73–79. [Google Scholar] [CrossRef]
  40. Meyer, G.M.J.; Wink, C.S.D.; Zapp, J.; Maurer, H.H. GC-MS, LC-MSn, LC-High Resolution-MSn, and NMR Studies on the Metabolism and Toxicological Detection of Mesembrine and Mesembrenone, the Main Alkaloids of the Legal High “Kanna” Isolated from Sceletium Tortuosum. Anal. Bioanal. Chem. 2015, 407, 761–778. [Google Scholar] [CrossRef]
  41. Gericke, J.; Harvey, B.H.; Pretorius, L.; Ollewagen, T.; Benecke, R.M.; Smith, C. Sceletium Tortuosum-Derived Mesembrine Significantly Contributes to the Anxiolytic Effect of Zembrin®, but Its Anti-Depressant Effect May Require Synergy of Multiple Plant Constituents. J. Ethnopharmacol. 2024, 319, 117113. [Google Scholar] [CrossRef] [PubMed]
  42. Pérard-Viret, J.; Souquet, F.; Manisse, M.-L.; Royer, J. An Expeditious Total Synthesis of (±)-Jamtine Using Condensation between Imine and Acid Anhydride. Tetrahedron Lett. 2010, 51, 96–98. [Google Scholar] [CrossRef]
  43. Logesh, R.; Das, N.; Adhikari-Devkota, A.; Devkota, H.P. Cocculus Hirsutus (L.) W.Theob. (Menispermaceae): A Review on Traditional Uses, Phytochemistry and Pharmacological Activities. Medicines 2020, 7, 69. [Google Scholar] [CrossRef]
  44. Thavamani, B.S.; Mathew, M.; Dhanabal, S. Cocculus Hirsutus: Molecular Docking to Identify Suitable Targets for Hepatocellular Carcinoma by in Silico Technique. Pharmacogn. Mag. 2016, 12, 350. [Google Scholar] [CrossRef]
  45. Ameena, S.; Rajesh, N.; Anjum, S.M.; Khadri, H.; Riazunnisa, K.; Mohammed, A.; Kari, Z.A. Antioxidant, Antibacterial, and Anti-Diabetic Activity of Green Synthesized Copper Nanoparticles of Cocculus Hirsutus (Menispermaceae). Appl. Biochem. Biotechnol. 2022, 194, 4424–4438. [Google Scholar] [CrossRef] [PubMed]
  46. Salve, N.R.; Mishra, D.N. Select Phytocompounds from Cocculus Hirsutus (L.) W. Theob. Extract Having Anti-Cancer Potential as Identified by LC-MS and in Silico Studies. Adv. Zool. Bot. 2024, 12, 47–62. [Google Scholar] [CrossRef]
  47. Renner, U.; Kernweisz, P. Alkaloide AusSchizozygia Caffaeoides (Boj.) Baill. Experientia 1963, 19, 244–246. [Google Scholar] [CrossRef]
  48. Kariba, R.M.; Houghton, P.J.; Yenesew, A. Antimicrobial Activities of a New Schizozygane Indoline Alkaloid from Schizozygia Coffaeoides and the Revised Structure of Isoschizogaline. J. Nat. Prod. 2002, 65, 566–569. [Google Scholar] [CrossRef]
  49. Xu, Z.; Bao, X.; Wang, Q.; Zhu, J. An Enantioselective Total Synthesis of (−)-Isoschizogamine. Angew. Chem. 2015, 127, 15150–15153. [Google Scholar] [CrossRef]
  50. Macel, M. Attract and Deter: A Dual Role for Pyrrolizidine Alkaloids in Plant–Insect Interactions. Phytochem. Rev. 2011, 10, 75–82. [Google Scholar] [CrossRef]
  51. Coulombe, R.A. Pyrrolizidine Alkaloids in Foods. Adv. Food Nutr. Res. 2003, 45, 61–99. [Google Scholar]
  52. Moreira, R.; Pereira, D.; Valentão, P.; Andrade, P. Pyrrolizidine Alkaloids: Chemistry, Pharmacology, Toxicology and Food Safety. Int. J. Mol. Sci. 2018, 19, 1668. [Google Scholar] [CrossRef] [PubMed]
  53. Wei, X.; Ruan, W.; Vrieling, K. Current Knowledge and Perspectives of Pyrrolizidine Alkaloids in Pharmacological Applications: A Mini-Review. Molecules 2021, 26, 1970. [Google Scholar] [CrossRef]
  54. Schramm, S.; Köhler, N.; Rozhon, W. Pyrrolizidine Alkaloids: Biosynthesis, Biological Activities and Occurrence in Crop Plants. Molecules 2019, 24, 498. [Google Scholar] [CrossRef]
  55. Desvergnes, S.; Py, S.; Vallée, Y. Total Synthesis of (+)-Hyacinthacine A 2 Based on SmI 2 -Induced Nitrone Umpolung. J. Org. Chem. 2005, 70, 1459–1462. [Google Scholar] [CrossRef]
  56. Mulholland, D.A.; Schwikkard, S.L.; Crouch, N.R. The Chemistry and Biological Activity of the Hyacinthaceae. Nat. Prod. Rep. 2013, 30, 1165. [Google Scholar] [CrossRef] [PubMed]
  57. Liddell, J.R. Pyrrolizidine Alkaloids (July 1998 to June 1999). Nat. Prod. Rep. 2000, 17, 455–462. [Google Scholar] [CrossRef] [PubMed]
  58. Gilles, P.; Py, S. SmI 2 -Mediated Cross-Coupling of Nitrones with β-Silyl Acrylates: Synthesis of (+)-Australine. Org. Lett. 2012, 14, 1042–1045. [Google Scholar] [CrossRef]
  59. Molyneux, R.J.; Benson, M.; Wong, R.Y.; Tropea, J.E.; Elbein, A.D. Australine, a Novel Pyrrolizidine Alkaloid Glucosidase Inhibitor from Castanospermum Australe. J. Nat. Prod. 1988, 51, 1198–1206. [Google Scholar] [CrossRef]
  60. Tropea, J.E.; Molyneux, R.J.; Kaushal, G.P.; Pan, Y.T.; Mitchell, M.; Elbein, A.D. Australine, a Pyrrolizidine Alkaloid That Inhibits Amyloglucosidase and Glycoprotein Processing. Biochemistry 1989, 28, 2027–2034. [Google Scholar] [CrossRef]
  61. Ziarani, G.M.; Jamasbi, N.; Mohajer, F. The Synthesis of Australine and Its Stereoisomers as Naturally Pyrrolizidine Alkaloids. Mini-Rev. Org. Chem. 2024, 21, 40–57. [Google Scholar] [CrossRef]
  62. Fayed, M.A.A. Heliotropium; a Genus Rich in Pyrrolizidine Alkaloids: A Systematic Review Following Its Phytochemistry and Pharmacology. Phytomedicine Plus 2021, 1, 100036. [Google Scholar] [CrossRef]
  63. Culvenor, C. The Alkaloids of Heliotropium Europaeum L.. II. Isolation and Structures of the Third Major Alkaloid and Two Monor Alkaloids, and Isolation of the Principal n-Oxides. Aust. J. Chem. 1954, 7, 287. [Google Scholar] [CrossRef]
  64. Pisaneschi, F.; Cordero, F.M.; Brandi, A. A Concise Total Synthesis of (+)-Heliotridine. Eur. J. Org. Chem. 2003, 2003, 4373–4375. [Google Scholar] [CrossRef]
  65. DE WAAL, H.L. South African Senecio Alkaloids. Nature 1940, 146, 777–778. [Google Scholar] [CrossRef]
  66. Nemoto, H.; Tanimoto, K.; Kanao, Y.; Omura, S.; Kita, Y.; Akai, S. Protecting-Group-Free Catalytic Asymmetric Total Synthesis of (−)-Rosmarinecine. Tetrahedron 2012, 68, 7295–7301. [Google Scholar] [CrossRef]
  67. Meinwald, J.; Smolanoff, J.; McPhail, A.T.; Miller, R.W.; Eisner, T.; Hicks, K. Nitropolyzonamine: A Spirocyclic Nitro Compound from the Defensive Glands of a Milliped (Polyzonium rosalbum). Tetrahedron Lett. 1975, 16, 2367–2370. [Google Scholar] [CrossRef]
  68. Kunert, O.; Pferschy-Wenzig, E.M.; Orthaber, A.; Raspotnig, G.; Bodner, M. Alkaloids from Millipedes: A Re-Evaluation of Defensive Exudates from Polyzonium Germanicum. Front. Ecol. Evol. 2023, 11, 1212452. [Google Scholar] [CrossRef]
  69. Mori, K.; Takagi, Y. Enantioselective Synthesis of Polyzonimine and Nitropolyzonamine, Spirocyclic Compounds from the Defensive Glands of a Millipede, Polyzonium Rosalbum. Tetrahedron Lett. 2000, 41, 6623–6625. [Google Scholar] [CrossRef]
  70. Michael, J.P. Simple Indolizidine and Quinolizidine Alkaloids. In The Alkaloids: Chemistry and Biology; Academic Press: Cambridge, MA, USA, 2016; pp. 1–498. [Google Scholar] [CrossRef]
  71. Michael, J.P. Simple Indolizidine and Quinolizidine Alkaloids. In The Alkaloids: Chemistry and Biology; Academic Press: Cambridge, MA, USA, 2001; pp. 91–258. [Google Scholar] [CrossRef]
  72. Cely-Veloza, W.; Kato, M.J.; Coy-Barrera, E. Quinolizidine-Type Alkaloids: Chemodiversity, Occurrence, and Bioactivity. ACS Omega 2023, 8, 27862–27893. [Google Scholar] [CrossRef]
  73. Snider, B.B.; Grabowski, J.F. Total Synthesis of (−)-Senepodine G and (−)-Cermizine C. J. Org. Chem. 2007, 72, 1039–1042. [Google Scholar] [CrossRef] [PubMed]
  74. Morita, H.; Hirasawa, Y.; Shinzato, T.; Kobayashi, J. New Phlegmarane-Type, Cernuane-Type, and Quinolizidine Alkaloids from Two Species of Lycopodium. Tetrahedron 2004, 60, 7015–7023. [Google Scholar] [CrossRef]
  75. Kitsiou, C.; Unsworth, W.P.; Coulthard, G.; Taylor, R.J.K. Substrate Scope in the Direct Imine Acylation of Ortho-Substituted Benzoic Acid Derivatives: The Total Synthesis (±)-Cavidine. Tetrahedron 2014, 70, 7172–7180. [Google Scholar] [CrossRef]
  76. Yu, H.; Jin, H.; Gong, W.; Wang, Z.; Liang, H. Pharmacological Actions of Multi-Target-Directed Evodiamine. Molecules 2013, 18, 1826–1843. [Google Scholar] [CrossRef]
  77. Sun, Q.; Xie, L.; Song, J.; Li, X. Evodiamine: A Review of Its Pharmacology, Toxicity, Pharmacokinetics and Preparation Researches. J. Ethnopharmacol. 2020, 262, 113164. [Google Scholar] [CrossRef]
  78. Panda, M.; Tripathi, S.K.; Zengin, G.; Biswal, B.K. Evodiamine as an Anticancer Agent: A Comprehensive Review on Its Therapeutic Application, Pharmacokinetic, Toxicity, and Metabolism in Various Cancers. Cell Biol. Toxicol. 2023, 39, 1–31. [Google Scholar] [CrossRef] [PubMed]
  79. Wang, Z.; Xiong, Y.; Peng, Y.; Zhang, X.; Li, S.; Peng, Y.; Peng, X.; Zhuo, L.; Jiang, W. Natural Product Evodiamine-Inspired Medicinal Chemistry: Anticancer Activity, Structural Optimization and Structure-Activity Relationship. Eur. J. Med. Chem. 2023, 247, 115031. [Google Scholar] [CrossRef]
  80. Solanki, R.; Patel, S. Evodiamine and Its Nano-based Approaches for Enhanced Cancer Therapy: Recent Advances and Challenges. J. Sci. Food Agric. 2024, 104, 8430–8444. [Google Scholar] [CrossRef] [PubMed]
  81. Li, W.; Wang, X.; Zhang, H.; He, Z.; Zhi, W.; Liu, F.; Wang, Y.; Niu, X. Anti-Ulcerogenic Effect of Cavidine against Ethanol-Induced Acute Gastric Ulcer in Mice and Possible Underlying Mechanism. Int. Immunopharmacol. 2016, 38, 450–459. [Google Scholar] [CrossRef] [PubMed]
  82. Niu, X.; Zhang, H.; Li, W.; Mu, Q.; Yao, H.; Wang, Y. Anti-Inflammatory Effects of Cavidine In Vitro and In Vivo, a Selective COX-2 Inhibitor in LPS-Induced Peritoneal Macrophages of Mouse. Inflammation 2015, 38, 923–933. [Google Scholar] [CrossRef]
  83. Niu, X.; Liu, F.; Li, W.; Zhi, W.; Zhang, H.; Wang, X.; He, Z. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-ΚB Signaling Pathway in Vivo and in Vitro. Inflammation 2017, 40, 1111–1122. [Google Scholar] [CrossRef] [PubMed]
  84. Song, D.; Wang, Z.; Mei, R.; Zhang, W.; Ma, D.; Xu, D.; Xie, X.; She, X. Short and Scalable Total Synthesis of Myrioneuron Alkaloids (±)-α,β-Myrifabral A and B. Org. Lett. 2016, 18, 669–671. [Google Scholar] [CrossRef] [PubMed]
  85. Pham, V.C.; Jossang, A.; Sévenet, T.; Nguyen, V.H.; Bodo, B. Absolute Configuration of Myrobotinol, New Fused-Hexacyclic Alkaloid Skeleton from Myrioneuron Nutans. J. Org. Chem. 2007, 72, 9826–9829. [Google Scholar] [CrossRef]
  86. Pham, V.C.; Jossang, A.; Sévenet, T.; Nguyen, V.H.; Bodo, B. Novel Alkaloids from Myrioneuron Nutans. Eur. J. Org. Chem. 2009, 2009, 1412–1416. [Google Scholar] [CrossRef]
  87. Smith, B.T.; Wendt, J.A.; Aubé, J. First Asymmetric Total Synthesis of (+)-Sparteine. Org. Lett. 2002, 4, 2577–2579. [Google Scholar] [CrossRef] [PubMed]
  88. Chuzel, O.; Riant, O. Sparteine as a Chiral Ligand for Asymmetric Catalysis. In Chiral Diazaligands for Asymmetric Synthesis; Springer: Berlin/Heidelberg, 2005; pp. 59–92. [Google Scholar]
  89. Dearden, M.J.; McGrath, M.J.; O’Brien, P. Evaluation of (+)-Sparteine-like Diamines for Asymmetric Synthesis. J. Org. Chem. 2004, 69, 5789–5792. [Google Scholar] [CrossRef] [PubMed]
  90. Zhao, S.; Sirasani, G.; Andrade, R.B. Aspidosperma and Strychnos Alkaloids: Chemistry and Biology. In The Alkaloids: Chemistry and Biology; Academic Press: Cambridge, MA, USA, 2021; pp. 1–143. [Google Scholar]
  91. de Almeida, V.L.; Silva, C.G.; Silva, A.F.; Campana, P.R.V.; Foubert, K.; Lopes, J.C.D.; Pieters, L. Aspidosperma Species: A Review of Their Chemistry and Biological Activities. J. Ethnopharmacol. 2019, 231, 125–140. [Google Scholar] [CrossRef] [PubMed]
  92. Lopchuk, J.M. Recent Advances in the Synthesis of Aspidosperma-Type Alkaloids. In Progress in Heterocyclic Chemistry; Elsevier: Amsterdam, The Netherlands, 2011; pp. 1–25. [Google Scholar]
  93. Wang, N.; Xiao, X.; Liu, C.; Yao, H.; Huang, N.; Zou, K. Recent Advances in the Total Synthesis of Aspidosperma and Kopsia Alkaloids Using Tetracyclic Pyridocarbazoles as Versatile Building Blocks. Adv. Synth. Catal. 2022, 364, 2479–2501. [Google Scholar] [CrossRef]
  94. Wang, N.; Jiang, X. Synthetic Approaches to Tricyclic Aminoketones in the Total Synthesis of Aspidosperma and Kopsia Alkaloids. Chem. Rec. 2021, 21, 295–314. [Google Scholar] [CrossRef]
  95. Goel, B.; Jain, S.K. Semisynthesis: Bridging Natural Products and Novel Anticancer Therapies. Eur. J. Med. Chem. Rep. 2024, 12, 100218. [Google Scholar] [CrossRef]
  96. Florencia, M.; Brunella, B. Commentary on the Obtention of Semi-Synthetic Derivatives from Natural Products for Medicinal Applications: Advances, Challenges, and Perspectives. Curr. Med. Chem. 2024, 32, 1–7. [Google Scholar] [CrossRef]
  97. Shemet, A.; Carreira, E.M. Total Synthesis of (−)-Rhazinilam and Formal Synthesis of (+)-Eburenine and (+)-Aspidospermidine: Asymmetric Cu-Catalyzed Propargylic Substitution. Org. Lett. 2017, 19, 5529–5532. [Google Scholar] [CrossRef]
  98. Kozmin, S.A.; Iwama, T.; Huang, Y.; Rawal, V.H. An Efficient Approach to Aspidosperma Alkaloids via [4 + 2] Cycloadditions of Aminosiloxydienes: Stereocontrolled Total Synthesis of (±)-Tabersonine. Gram-Scale Catalytic Asymmetric Syntheses of (+)-Tabersonine and (+)-16-Methoxytabersonine. Asymmetric Sy. J. Am. Chem. Soc. 2002, 124, 4628–4641. [Google Scholar] [CrossRef] [PubMed]
  99. Wang, N.; Du, S.; Li, D.; Jiang, X. Divergent Asymmetric Total Synthesis of (+)-Vincadifformine, (−)-Quebrachamine, (+)-Aspidospermidine, (−)-Aspidospermine, (−)-Pyrifolidine, and Related Natural Products. Org. Lett. 2017, 19, 3167–3170. [Google Scholar] [CrossRef]
  100. Banwell, M.G.; Lupton, D.W.; Willis, A.C. Application of the Palladium(0)-Catalyzed Ullmann Cross-Coupling Reaction in a Total Synthesis of (±)-Aspidospermidine and Thus Representing an Approach to the Lower Hemisphere of the Binary Indole—Indoline Alkaloid Vinblastine. Aust. J. Chem. 2005, 58, 722. [Google Scholar] [CrossRef]
  101. Gnecco, D.; Vázquez, E.; Galindo, A.; Terán, J.L.; Orea, L.; Bernès, S.; Enríquez, R.G. Synthesis of an Aspidosperma Alkaloid Precursor: Synthesis of (+)-Aspidospermidine. Arkivoc 2003, 2003, 185–192. [Google Scholar] [CrossRef]
  102. Toczko, M.A.; Heathcock, C.H. Total Synthesis of (±)-Aspidospermidine. J. Org. Chem. 2000, 65, 2642–2645. [Google Scholar] [CrossRef]
  103. Serdaroglu, G.; Uludag, N. Concise Total Synthesis of (±)-Aspidospermidine and Computational Study: FT-IR, NMR, NBO, NLO, FMO, MEP Diagrams. J. Mol. Struct. 2018, 1166, 286–303. [Google Scholar] [CrossRef]
  104. Antropow, A.H.; Garcia, N.R.; White, K.L.; Movassaghi, M. Enantioselective Synthesis of (−)-Vallesine: Late-Stage C17-Oxidation via Complex Indole Boronation. Org. Lett. 2018, 20, 3647–3650. [Google Scholar] [CrossRef]
  105. Akhgari, A.; Laakso, I.; Seppänen-Laakso, T.; Yrjönen, T.; Vuorela, H.; Oksman-Caldentey, K.; Rischer, H. Determination of Terpenoid Indole Alkaloids in Hairy Roots of Rhazya Stricta (Apocynaceae) by GC-MS. Phytochem. Anal. 2015, 26, 331–338. [Google Scholar] [CrossRef] [PubMed]
  106. Madni, A.; Iqbal, M.A.; Batool, R.; Mahmood, A.; Riaz, H.; Hasnain, M.; Akram, M.A.; Zahid, A. Evaluation of Chemical Composition of Ethanolic Extract of Rhazya Stricta and Its Total Phenolic and Flavonoid Contents. Chem. Afr. 2022, 5, 533–542. [Google Scholar] [CrossRef]
  107. Fukuda, Y.; Shindo, M.; Shishido, K. Total Synthesis of (−)-Aspidospermine via Diastereoselective Ring-Closing Olefin Metathesis. Org. Lett. 2003, 5, 749–751. [Google Scholar] [CrossRef] [PubMed]
  108. Deutsch, H.F.; Evenson, M.A.; Drescher, P.; Sparwasser, C.; Madsen, P.O. Isolation and Biological Activity of Aspidospermine and Quebrachamine from an Aspidosperma Tree Source. J. Pharm. Biomed. Anal. 1994, 12, 1283–1287. [Google Scholar] [CrossRef]
  109. Mitaine-Offer, A.-C.; Sauvain, M.; Valentin, A.; Callapa, J.; Mallié, M.; Zèches-Hanrot, M. Antiplasmodial Activity of Aspidosperma Indole Alkaloids. Phytomedicine 2002, 9, 142–145. [Google Scholar] [CrossRef] [PubMed]
  110. Heravi, M.M.; Amiri, Z.; Kafshdarzadeh, K.; Zadsirjan, V. Synthesis of Indole Derivatives as Prevalent Moieties Present in Selected Alkaloids. RSC Adv. 2021, 11, 33540–33612. [Google Scholar] [CrossRef] [PubMed]
  111. Liu, Z.; Ju, X.; Ma, S.; Du, C.; Zhang, W.; Li, H.; Wang, X.; Xie, X.; She, X. Asymmetric Total Synthesis of (+)-Winchinine B. J. Org. Chem. 2019, 84, 14994–15000. [Google Scholar] [CrossRef]
  112. Li, Y.-T.; Gao, X.-D.; Zhang, W.; Huang, X.-J.; Zhang, D.-M.; Jiang, R.-W.; Wang, L.; Zhang, X.-Q.; Ye, W.-C. Winchinines A and B, Two Unusual Monoterpene Indole Alkaloids with a Third Nitrogen Atom from Winchia Calophylla. RSC Adv. 2016, 6, 59657–59660. [Google Scholar] [CrossRef]
  113. Lee, K.; Boger, D.L. Total Syntheses of (−)-Kopsifoline D and (−)-Deoxoapodine: Divergent Total Synthesis via Late-Stage Key Strategic Bond Formation. J. Am. Chem. Soc. 2014, 136, 3312–3317. [Google Scholar] [CrossRef]
  114. Zhao, S.; Andrade, R.B. Development and Scope of the Arene-Fused Domino Michael/Mannich Reaction: Application to the Total Syntheses of Aspidosperma Alkaloids (−)-Aspidospermidine, (−)-Tabersonine, and (−)-Vincadifformine. J. Org. Chem. 2017, 82, 521–531. [Google Scholar] [CrossRef]
  115. Zhao, S.; Andrade, R.B. Domino Michael/Mannich/ N -Alkylation Route to the Tetrahydrocarbazole Framework of Aspidosperma Alkaloids: Concise Total Syntheses of (−)-Aspidospermidine, (−)-Tabersonine, and (−)-Vincadifformine. J. Am. Chem. Soc. 2013, 135, 13334–13337. [Google Scholar] [CrossRef]
  116. Wagnières, O.; Xu, Z.; Wang, Q.; Zhu, J. Unified Strategy to Monoterpene Indole Alkaloids: Total Syntheses of (±)-Goniomitine, (±)-1,2-Dehydroaspidospermidine, (±)-Aspidospermidine, (±)-Vincadifformine, and (±)-Kopsihainanine A. J. Am. Chem. Soc. 2014, 136, 15102–15108. [Google Scholar] [CrossRef] [PubMed]
  117. Kai, T.; Zhang, L.; Wang, X.; Jing, A.; Zhao, B.; Yu, X.; Zheng, J.; Zhou, F. Tabersonine Inhibits Amyloid Fibril Formation and Cytotoxicity of Aβ(1–42). ACS Chem. Neurosci. 2015, 6, 879–888. [Google Scholar] [CrossRef]
  118. Qian, C.; Wang, J.; Lin, W.; Chen, Y.; Yang, J.; Liu, M.; Sun, X.; Wu, H.; Zhang, M.; Wang, Y.; et al. Tabersonine Attenuates Obesity-induced Renal Injury via Inhibiting NF-κB-mediated Inflammation. Phytother. Res. 2023, 37, 2353–2363. [Google Scholar] [CrossRef]
  119. Li, X.; Li, X.; Chen, L.; Deng, Y.; Zheng, Z.; Ming, Y. Tabersonine Induces the Apoptosis of Human Hepatocellular Carcinoma In Vitro and In Vivo. Anti-Cancer Agents Med. Chem. 2024, 24, 764–772. [Google Scholar] [CrossRef] [PubMed]
  120. Chen, X.; Yan, Y.; Liu, Y.; Yi, Q.; Xu, Z. Tabersonine Enhances Cisplatin Sensitivity by Modulating Aurora Kinase A and Suppressing Epithelial–Mesenchymal Transition in Triple-Negative Breast Cancer. Pharm. Biol. 2024, 62, 394–403. [Google Scholar] [CrossRef] [PubMed]
  121. Xu, H.; Li, W.; Hong, S.; Shao, J.; Chen, J.; Chattipakorn, N.; Wu, D.; Luo, W.; Liang, G. Tabersonine, a Natural NLRP3 Inhibitor, Suppresses Inflammasome Activation in Macrophages and Attenuate NLRP3-Driven Diseases in Mice. Acta Pharmacol. Sin. 2023, 44, 1252–1261. [Google Scholar] [CrossRef]
  122. Shen, X.-L.; Zhao, R.-R.; Mo, M.-J.; Peng, F.-Z.; Zhang, H.-B.; Shao, Z.-H. Catalytic Enantioselective and Divergent Total Synthesis of (+)-10-Oxocylindrocarpidine, (+)-Cylindrocarpidine, (−)- N -Acetylcylindrocarpinol, and (+)-Aspidospermine. J. Org. Chem. 2014, 79, 2473–2480. [Google Scholar] [CrossRef]
  123. He, W.; Hu, J.; Wang, P.; Chen, L.; Ji, K.; Yang, S.; Li, Y.; Xie, Z.; Xie, W. Highly Enantioselective Tandem Michael Addition of Tryptamine-Derived Oxindoles to Alkynones: Concise Synthesis of Strychnos Alkaloids. Angew. Chem. 2018, 130, 3868–3871. [Google Scholar] [CrossRef]
  124. Liu, X.; Lou, M.; Bai, S.; Sun, G.; Qi, X. Asymmetric Total Syntheses of Strychnos Alkaloids via Selective Fischer Indolization. J. Org. Chem. 2022, 87, 5199–5212. [Google Scholar] [CrossRef]
  125. Uludag, N. An Effective Approach to the Strychnos Alkaloids: Total Synthesis of Tubifolidine. Chem. Nat. Compd. 2021, 57, 491–496. [Google Scholar] [CrossRef]
  126. Pandey, G.; Khamrai, J.; Mishra, A.; Maity, P.; Chikkade, P.K. Iminium Ion-Enamine Cascade Reaction Enables the Asymmetric Total Syntheses of Aspidosperma Alkaloids Vincadifformine and Ervinceine. Tetrahedron 2018, 74, 6317–6327. [Google Scholar] [CrossRef]
  127. Pandey, G.; Prasanna, K.C. Iminium Ion Cascade Reaction in the Total Synthesis of (+)-Vincadifformine. Org. Lett. 2011, 13, 4672–4675. [Google Scholar] [CrossRef]
  128. Sumi, S.; Matsumoto, K.; Tokuyama, H.; Fukuyama, T. Enantioselective Total Synthesis of Aspidophytine. Org. Lett. 2003, 5, 1891–1893. [Google Scholar] [CrossRef]
  129. Satoh, H.; Ueda, H.; Tokuyama, H. Divergent Total Synthesis of (−)-Aspidophytine and Its Congeners via Fischer Indole Synthesis. Tetrahedron 2013, 69, 89–95. [Google Scholar] [CrossRef]
  130. Banwell, M.G.; White, L.V.; Ye, S.Y. Formal Total Syntheses of (+)- and (−)-Aspidophytine from a Common, Homochiral Precursor. J. Org. Chem. 2022, 87, 14407–14421. [Google Scholar] [CrossRef] [PubMed]
  131. Mroue, M.A.; Euler, K.L.; Ghuman, M.A.; Alam, M. Indole Alkaloids of Haplophyton Crooksii. J. Nat. Prod. 1996, 59, 890–893. [Google Scholar] [CrossRef]
  132. Dey, P.; Kundu, A.; Chakraborty, H.J.; Kar, B.; Choi, W.S.; Lee, B.M.; Bhakta, T.; Atanasov, A.G.; Kim, H.S. Therapeutic Value of Steroidal Alkaloids in Cancer: Current Trends and Future Perspectives. Int. J. Cancer 2019, 145, 1731–1744. [Google Scholar] [CrossRef]
  133. Jiang, Q.; Chen, M.; Cheng, K.; Yu, P.; Wei, X.; Shi, Z. Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases. Med. Res. Rev. 2016, 36, 119–143. [Google Scholar] [CrossRef]
  134. Huang, Y.; Li, G.; Hong, C.; Zheng, X.; Yu, H.; Zhang, Y. Potential of Steroidal Alkaloids in Cancer: Perspective Insight Into Structure–Activity Relationships. Front. Oncol. 2021, 11, 733369. [Google Scholar] [CrossRef] [PubMed]
  135. Troost, B.; Mulder, L.M.; Diosa-Toro, M.; van de Pol, D.; Rodenhuis-Zybert, I.A.; Smit, J.M. Tomatidine, a Natural Steroidal Alkaloid Shows Antiviral Activity towards Chikungunya Virus in Vitro. Sci. Rep. 2020, 10, 6364. [Google Scholar] [CrossRef] [PubMed]
  136. Yan, Y.; Li, X.; Zhang, C.; Lv, L.; Gao, B.; Li, M. Research Progress on Antibacterial Activities and Mechanisms of Natural Alkaloids: A Review. Antibiotics 2021, 10, 318. [Google Scholar] [CrossRef] [PubMed]
  137. Lin, B.; Xu, P.; Zheng, J.; Deng, X.; Ye, Q.; Huang, Z.; Wang, N. Effects and Mechanisms of Natural Alkaloids for Prevention and Treatment of Osteoporosis. Front. Pharmacol. 2022, 13, 1014173. [Google Scholar] [CrossRef] [PubMed]
  138. Zhang, Z.-D.; Shi, Y.; Wu, J.-J.; Lin, J.-R.; Tian, W.-S. Synthesis of Demissidine and Solanidine. Org. Lett. 2016, 18, 3038–3040. [Google Scholar] [CrossRef] [PubMed]
  139. Vronen, P.J.E.; Koval, N.; Groot, A. de The Synthesis of 16-Dehydropregnenolone Acetate (DPA) from Potato Glycoalkaloids. Arkivoc 2003, 2004, 24–50. [Google Scholar] [CrossRef]
  140. Wollmann, B.M.; Størset, E.; Kringen, M.K.; Molden, E.; Smith, R.L. Prediction of CYP2D6 Poor Metabolizers by Measurements of Solanidine and Metabolites—A Study in 839 Patients with Known CYP2D6 Genotype. Eur. J. Clin. Pharmacol. 2023, 79, 523–531. [Google Scholar] [CrossRef]
  141. Medwid, S.; Schwarz, U.I.; Choi, Y.; Keller, D.; Ross, C.; Kim, R.B. Solanidine Metabolites as Diet-Derived Biomarkers of CYP2D6-Mediated Tamoxifen Metabolism in Breast Cancer Patients. Clin. Pharmacol. Ther. 2024, 116, 1269–1277. [Google Scholar] [CrossRef] [PubMed]
  142. Wojtkielewicz, A.; Kiełczewska, U.; Baj, A.; Morzycki, J.W. Synthesis of Demissidine Analogues from Tigogenin via Imine Intermediates. Int. J. Mol. Sci. 2021, 22, 10879. [Google Scholar] [CrossRef] [PubMed]
  143. Zhao, B.-X.; Wang, Y.; Zhang, D.-M.; Jiang, R.-W.; Wang, G.-C.; Shi, J.-M.; Huang, X.-J.; Chen, W.-M.; Che, C.-T.; Ye, W.-C. Flueggines A and B, Two New Dimeric Indolizidine Alkaloids from Flueggea Virosa. Org. Lett. 2011, 13, 3888–3891. [Google Scholar] [CrossRef]
  144. Bailly, C. Traditional Uses, Pharmacology and Phytochemistry of the Medicinal Plant Flueggea Virosa (Roxb. Ex Willd.) Royle. Future Pharmacol. 2024, 4, 77–102. [Google Scholar] [CrossRef]
  145. Wei, H.; Qiao, C.; Liu, G.; Yang, Z.; Li, C. Stereoselective Total Syntheses of (−)-Flueggine A and (+)-Virosaine B. Angew. Chem. 2013, 125, 648–652. [Google Scholar] [CrossRef]
  146. Ma, N.; Yao, Y.; Zhao, B.-X.; Wang, Y.; Ye, W.-C.; Jiang, S. Total Synthesis of Securinega Alkaloids (−)-Norsecurinine, (−)-Niruroidine and (−)-Flueggine A. Chem. Commun. 2014, 50, 9284–9287. [Google Scholar] [CrossRef] [PubMed]
  147. Li, L.-M.; Yang, T.; Liu, Y.; Liu, J.; Li, M.-H.; Wang, Y.-T.; Yang, S.-X.; Zou, Q.; Li, G.-Y. Calophyline A, a New Rearranged Monoterpenoid Indole Alkaloid from Winchia Calophylla. Org. Lett. 2012, 14, 3450–3453. [Google Scholar] [CrossRef]
  148. Li, G.; Xie, X.; Zu, L. Total Synthesis of Calophyline A. Angew. Chem. 2016, 128, 10639–10642. [Google Scholar] [CrossRef]
  149. Xie, X.; Wei, B.; Li, G.; Zu, L. Unified Total Syntheses of Structurally Diverse Akuammiline Alkaloids. Org. Lett. 2017, 19, 5430–5433. [Google Scholar] [CrossRef] [PubMed]
  150. Gan, C.-Y.; Etoh, T.; Hayashi, M.; Komiyama, K.; Kam, T.-S. Leucoridines A−D, Cytotoxic Strychnos − Strychnos Bisindole Alkaloids from Leuconotis. J. Nat. Prod. 2010, 73, 1107–1111. [Google Scholar] [CrossRef]
  151. Kokkonda, P.; Brown, K.R.; Seguin, T.J.; Wheeler, S.E.; Vaddypally, S.; Zdilla, M.J.; Andrade, R.B. Biomimetic Total Syntheses of (−)-Leucoridines A and C through the Dimerization of (−)-Dihydrovalparicine. Angew. Chem. 2015, 127, 12823–12826. [Google Scholar] [CrossRef]
  152. Benayad, S.; Beniddir, M.A.; Evanno, L.; Poupon, E. Biomimetic Assembly of Leucoridine A. Eur. J. Org. Chem. 2015, 2015, 1894–1898. [Google Scholar] [CrossRef]
Figure 1. Example of alkaloids synthesized from imines.
Figure 1. Example of alkaloids synthesized from imines.
Ijms 26 00288 g001
Scheme 1. Synthesis of (-)-Swainsonine.
Scheme 1. Synthesis of (-)-Swainsonine.
Ijms 26 00288 sch001
Scheme 2. Synthesis of (±)-Indolizidine 209D.
Scheme 2. Synthesis of (±)-Indolizidine 209D.
Ijms 26 00288 sch002
Scheme 3. Synthesis of (+)-Serratezomine A.
Scheme 3. Synthesis of (+)-Serratezomine A.
Ijms 26 00288 sch003
Scheme 4. Synthesis of (±)-Crispine A and (±)-Harmicine.
Scheme 4. Synthesis of (±)-Crispine A and (±)-Harmicine.
Ijms 26 00288 sch004
Scheme 5. Synthesis of (+)-Crispine A, (+)-Harmicine and (+)-Desbromarborescidine.
Scheme 5. Synthesis of (+)-Crispine A, (+)-Harmicine and (+)-Desbromarborescidine.
Ijms 26 00288 sch005
Scheme 6. Synthesis of (±)-Δ7-Mesembrenon.
Scheme 6. Synthesis of (±)-Δ7-Mesembrenon.
Ijms 26 00288 sch006
Scheme 7. Synthesis of (±)-Jamtine.
Scheme 7. Synthesis of (±)-Jamtine.
Ijms 26 00288 sch007
Scheme 8. Synthesis of (-)-Isoschizogamine.
Scheme 8. Synthesis of (-)-Isoschizogamine.
Ijms 26 00288 sch008
Scheme 9. Synthesis of (+)-Hyacinthacine A2.
Scheme 9. Synthesis of (+)-Hyacinthacine A2.
Ijms 26 00288 sch009
Scheme 10. Synthesis of (+)-Australine.
Scheme 10. Synthesis of (+)-Australine.
Ijms 26 00288 sch010
Scheme 11. Synthesis of (+)-Heliotridine.
Scheme 11. Synthesis of (+)-Heliotridine.
Ijms 26 00288 sch011
Scheme 12. Synthesis of (-)-Rosmarinecine.
Scheme 12. Synthesis of (-)-Rosmarinecine.
Ijms 26 00288 sch012
Scheme 13. Synthesis of (+)-Nitropolyzonamine.
Scheme 13. Synthesis of (+)-Nitropolyzonamine.
Ijms 26 00288 sch013
Scheme 14. Synthesis of (-)-Cermizine C.
Scheme 14. Synthesis of (-)-Cermizine C.
Ijms 26 00288 sch014
Scheme 15. Synthesis of Evodiamine and Cavidine.
Scheme 15. Synthesis of Evodiamine and Cavidine.
Ijms 26 00288 sch015
Scheme 16. Synthesis of (±)-α,β-Myrifabral A and B.
Scheme 16. Synthesis of (±)-α,β-Myrifabral A and B.
Ijms 26 00288 sch016
Scheme 17. Synthesis of (+)-Sparteine.
Scheme 17. Synthesis of (+)-Sparteine.
Ijms 26 00288 sch017
Scheme 18. Synthesis of (+)-Aspidospermidine.
Scheme 18. Synthesis of (+)-Aspidospermidine.
Ijms 26 00288 sch018
Scheme 19. Synthesis of (-)-Aspidospermine.
Scheme 19. Synthesis of (-)-Aspidospermine.
Ijms 26 00288 sch019
Scheme 20. Synthesis of (+)-Winchinine.
Scheme 20. Synthesis of (+)-Winchinine.
Ijms 26 00288 sch020
Scheme 21. Synthesis of (-)-Kopsifoline D hydrate.
Scheme 21. Synthesis of (-)-Kopsifoline D hydrate.
Ijms 26 00288 sch021
Scheme 22. Synthesis of (−)-Tabersonine, (−)-Vincadifformine, and (−)-Aspidospermidine.
Scheme 22. Synthesis of (−)-Tabersonine, (−)-Vincadifformine, and (−)-Aspidospermidine.
Ijms 26 00288 sch022
Scheme 23. Synthesis of (+)-10-Oxocylindrocarpidine, (+)-Cylindrocarpidine, and (+)-Aspidospermine.
Scheme 23. Synthesis of (+)-10-Oxocylindrocarpidine, (+)-Cylindrocarpidine, and (+)-Aspidospermine.
Ijms 26 00288 sch023
Scheme 24. Synthesis of (-)-Tubifolidin.
Scheme 24. Synthesis of (-)-Tubifolidin.
Ijms 26 00288 sch024
Scheme 25. Synthesis of (-)-Tubifolidin.
Scheme 25. Synthesis of (-)-Tubifolidin.
Ijms 26 00288 sch025
Scheme 26. Synthesis of (+)-Vincadifformine and (+)-Ervinceine.
Scheme 26. Synthesis of (+)-Vincadifformine and (+)-Ervinceine.
Ijms 26 00288 sch026
Scheme 27. Synthesis of (-)-Aspidophytine.
Scheme 27. Synthesis of (-)-Aspidophytine.
Ijms 26 00288 sch027
Scheme 28. Synthesis of Solanidine.
Scheme 28. Synthesis of Solanidine.
Ijms 26 00288 sch028
Scheme 29. Synthesis of Demissidine.
Scheme 29. Synthesis of Demissidine.
Ijms 26 00288 sch029
Scheme 30. Synthesis of (-)-Flueggine A.
Scheme 30. Synthesis of (-)-Flueggine A.
Ijms 26 00288 sch030
Scheme 31. Synthesis of Calofilin A.
Scheme 31. Synthesis of Calofilin A.
Ijms 26 00288 sch031
Scheme 32. Synthesis of (-)-Leucoridins A and C.
Scheme 32. Synthesis of (-)-Leucoridins A and C.
Ijms 26 00288 sch032
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Smolobochkin, A.; Gazizov, A.; Sidlyaruk, N.; Akylbekov, N.; Zhapparbergenov, R.; Burilov, A. Cyclic Imines and Their Salts as Universal Precursors in the Synthesis of Nitrogen-Containing Alkaloids. Int. J. Mol. Sci. 2025, 26, 288. https://doi.org/10.3390/ijms26010288

AMA Style

Smolobochkin A, Gazizov A, Sidlyaruk N, Akylbekov N, Zhapparbergenov R, Burilov A. Cyclic Imines and Their Salts as Universal Precursors in the Synthesis of Nitrogen-Containing Alkaloids. International Journal of Molecular Sciences. 2025; 26(1):288. https://doi.org/10.3390/ijms26010288

Chicago/Turabian Style

Smolobochkin, Andrey, Almir Gazizov, Nikita Sidlyaruk, Nurgali Akylbekov, Rakhmetulla Zhapparbergenov, and Alexander Burilov. 2025. "Cyclic Imines and Their Salts as Universal Precursors in the Synthesis of Nitrogen-Containing Alkaloids" International Journal of Molecular Sciences 26, no. 1: 288. https://doi.org/10.3390/ijms26010288

APA Style

Smolobochkin, A., Gazizov, A., Sidlyaruk, N., Akylbekov, N., Zhapparbergenov, R., & Burilov, A. (2025). Cyclic Imines and Their Salts as Universal Precursors in the Synthesis of Nitrogen-Containing Alkaloids. International Journal of Molecular Sciences, 26(1), 288. https://doi.org/10.3390/ijms26010288

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop